Trial reportJMIR medical education2026
Remote Augmented Reality Versus Traditional Simulation for Team Leader Assessment in a Cardiac Arrest Scenario: Noninferiority Randomized Controlled Trial.
Trial report in JMIR medical education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Simulation-based education is crucial for training health care professionals in advanced cardiac life support. However, access to high-fidelity in-person simulation is frequently limited by geographic, logistical, and financial constraints. Augmented reality (AR) offers the potential to deliver remote, immersive training experiences that may overcome these barriers, but its effectiveness compared with traditional simulation remains uncertain. Objective: This study aimed to determine whether remote AR simulation is noninferior to traditional in-person simulation for assessing team leader performance during a ventricular fibrillation cardiac arrest scenario. Methods: This noninferiority randomized trial enrolled participants at the State University of Campinas (UNICAMP), Brazil, and used cross-continental remote instruction from Stanford University (in the United States) for the AR arm. A total of 50 health care professionals were randomized to either remote AR simulation with a geographically distant instructor (n=25) or traditional in-person simulation (n=25). All participants completed an identical ventricular fibrillation cardiac arrest case as team leaders. Leader performance was assessed using an adapted, validated checklist-based instrument for cognitive leadership and an observational behavioral measure (Behaviorally Anchored Rating Scale). Secondary outcomes included AR participants' evaluations of usability and ergonomics. Results: A total of 42 participants fully completed the study procedures (remote AR group: n=22; traditional in-person group: n=20). The AR group demonstrated noninferior performance compared to the traditional group across all outcomes. The mean checklist scores were 41.6 (SD 6.2) and 42.6 (SD 5.8) in the remote AR group and traditional in-person group, respectively. The AR group's 95% CI (38.9-44.4) was above the 20% noninferiority threshold of 34.1. Usability and ergonomics were favorably reported by most participants. Conclusions: Participants in the remote AR simulation demonstrated noninferior team leader decision-making and behavioral performance compared with those in traditional in-person simulation. These findings suggest that remote AR may be a viable strategy to expand access to scenario-based assessment of cardiac arrest leadership, particularly in resource-limited settings. AR participants also reported high usability and low ergonomic burden, indicating comfortable headset use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.